Molecular biology reports

Liraglutide reduces lung and muscle damage in diabetes by affecting inflammation and muscle repair pathways

Updated

Abstract

Liraglutide treatment significantly ameliorated molecular and structural alterations in both lung and skeletal muscle tissues in diabetic rats.

  • Diabetic rats showed significant hyperglycemia and dyslipidemia.
  • Levels of methylglyoxal and hypoxia-inducible factor-1α (HIF-1α) were elevated in diabetic rats.
  • Increased oxidative stress and inflammation were noted in the lung tissue of diabetic rats.
  • Skeletal muscle of diabetic rats exhibited signs of muscle atrophy.
  • Liraglutide may protect against oxidative stress, inflammation, and atrophy-related signaling pathways in both lung and skeletal muscle.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declarations. Competing interests: The authors declare no competing interests. Ethical approval and Consent to participate: All experimental procedures were conducted in accordance with BSU-IACUC guidelines, approval number: SCIBUS-IACUC-024B2. Consent for publication: all authors agree publication in this journal.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free